Literature DB >> 11311552

Gene structure and enzymatic activity of mouse eosinophil-associated ribonuclease 2.

A L McDevitt1, M S Deming, H F Rosenberg, K D Dyer.   

Abstract

Mouse eosinophil-associated ribonuclease-2 (mEAR-2) is one of a cluster of genes identified in the genome of the mouse Mus musculus that are highly divergent orthologs of the primate ribonucleases, eosinophil-derived neurotoxin (EDN) and eosinophil cationic protein (ECP). Northern analysis revealed expression of genes hybridizing to mEAR-2 in mouse lung, liver and spleen tissues. We obtained full-length cDNA by hybridization screening of mouse eosinophil and lung cDNA libraries and by rapid amplification of cDNA ends (RACE) from liver, spleen and lung RNA. Using these methods we have isolated the 195 base pair (bp) 3' untranslated region (UTR) that includes a typical polyadenylation signal preceding a poly A tail and the 5' UTR which includes 63-71 bp and three distinct transcriptional start sites. Using unidirectional PCR we isolated a 361-bp 5' promoter region and delineated the intronic / exonic boundaries which include a non-coding exon 1, a single intron, and a coding exon 2, a structure that is typical of genes of the RNase A superfamily. Consensus sites for PU.1 and EoTF, both active as intronic enhancer elements of the gene encoding EDN, are also present in the intron of the gene encoding mEAR-2. The catalytic activity of recombinant baculovirus-derived mEAR-2 is similar to that of rhEDN from this source, with catalytic constants k(cat)/K(m)=5.6x10(6) M(-1) s(-1) and 10.5x10(6) M(-1) s(-1), respectively, against a standard yeast tRNA substrate. Sequence analysis of the non-coding regions and enzymatic characterization of the gene product provide further evidence indicating that mEAR-2 is a structural and functional ortholog of primate EDNs and ECPs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11311552     DOI: 10.1016/s0378-1119(01)00392-4

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  7 in total

1.  Complementary advantageous substitutions in the evolution of an antiviral RNase of higher primates.

Authors:  Jianzhi Zhang; Helene F Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-26       Impact factor: 11.205

2.  Eosinophil-associated ribonuclease 11 is a macrophage chemoattractant.

Authors:  Kelsey J Yamada; Tolga Barker; Kimberly D Dyer; Tyler A Rice; Caroline M Percopo; Katia E Garcia-Crespo; Soochin Cho; James J Lee; Kirk M Druey; Helene F Rosenberg
Journal:  J Biol Chem       Date:  2015-02-20       Impact factor: 5.157

3.  Isolation, characterization, and evolutionary divergence of mouse RNase 6: evidence for unusual evolution in rodents.

Authors:  Kimberly D Dyer; Helene F Rosenberg; Jianzhi Zhang
Journal:  J Mol Evol       Date:  2004-11       Impact factor: 2.395

4.  Identification of a purine-rich intronic enhancer element in the mouse eosinophil-associated ribonuclease 2 (mEar 2) gene.

Authors:  Kimberly D Dyer; Takeaki Nitto; Joanne M Moreau; Amanda L McDevitt; Helene F Rosenberg
Journal:  Mamm Genome       Date:  2004-02       Impact factor: 2.957

5.  Integrating computationally assembled mouse transcript sequences with the Mouse Genome Informatics (MGI) database.

Authors:  Yunxia Zhu; Benjamin L King; Babak Parvizi; Brian P Brunk; Christian J Stoeckert; John Quackenbush; Joel Richardson; Carol J Bult
Journal:  Genome Biol       Date:  2003-02-03       Impact factor: 13.583

6.  The first crystal structure of human RNase 6 reveals a novel substrate-binding and cleavage site arrangement.

Authors:  Guillem Prats-Ejarque; Javier Arranz-Trullén; Jose A Blanco; David Pulido; M Victòria Nogués; Mohammed Moussaoui; Ester Boix
Journal:  Biochem J       Date:  2016-03-24       Impact factor: 3.857

Review 7.  The Immunomodulatory and Antimicrobial Properties of the Vertebrate Ribonuclease A Superfamily.

Authors:  Laura Schwartz; Ariel Cohen; Jason Thomas; John David Spencer
Journal:  Vaccines (Basel)       Date:  2018-11-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.